BOK Financial’s AbbVie ABBV Stock Holding History

BOK Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90	Closed	-$324K	–	1069
2023 Q1	$324K	Buy	+90	New	+$13.8K	0.01%	616

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BOK Financial's ABBV Position: Q1 2026 in Review

BOK Financial reduced its AbbVie (ABBV) stake by 8.8% in Q1 2026, selling an estimated $4.33M and leaving 201,240 shares worth $43.8M. The position accounts for 0.67% of the portfolio, ranked #30.

BOK Financial first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $123M in Q1 2021. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

BOK Financial held 201,240 shares of AbbVie worth $43.8M as of Q1 2026.
BOK Financial sold 19,503 AbbVie shares in Q1 2026, an estimated $4.33M.
AbbVie made up 0.67% of BOK Financial's portfolio in Q1 2026, its #30 holding.
BOK Financial first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
BOK Financial's AbbVie position peaked at $123M in Q1 2021.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.